UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000030105 |
|---|---|
| Receipt number | R000034366 |
| Scientific Title | Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG |
| Date of disclosure of the study information | 2017/11/24 |
| Last modified on | 2023/07/25 11:36:15 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG
Acronym
Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG
Scientific Title
Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG
Scientific Title:Acronym
Optimum dose of Landiolol Hydrochloride for heart-rate control during On-pump beating heart (OPBH) CABG
Region
| Japan |
Condition
Condition
coronary artery bypass grafting
Classification by specialty
| Anesthesiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
investigation for optimal dose of Landiolol Hydrochloride for on-pump beating-heart CABG
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
dose of landiolol and heart rate during on pump beating heart
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
dose of landiolol is not loaded, and increased every 10 minutes from 5 mcl/kg/min,15mcl/kg/min , 25 mcl/kg/min,35mcl/kg/min.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 90 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Patients scheduled for on-pump beating-heart technique CABG for surgical revascularization with general anesthesia
Key exclusion criteria
Patients who can not obtain informed consent
Patients judged inappropriate by the physician in charge of this study
Patients with atrial fibrillation
Target sample size
35
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | kawashima shingo |
Organization
Hamamatsu University School of Medicine
Division name
Department of Anesthesiology and Intensive Care
Zip code
Address
1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan
TEL
0534352111
shingogo@hama-med.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | kawashima shingo |
Organization
Hamamatsu University School of Medicine
Division name
Department of Anesthesiology and Intensive Care
Zip code
Address
1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan
TEL
0534352111
Homepage URL
shingogo@hama-med.ac.jp
Sponsor or person
Institute
HAMAMATSU UNIVERSITY HOSPITAL
Institute
Department
Personal name
Funding Source
Organization
HAMAMATSU UNIVERSITY HOSPITAL
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 11 | Month | 24 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 10 | Month | 01 | Day |
Date of IRB
| 2011 | Year | 12 | Month | 01 | Day |
Anticipated trial start date
| 2017 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2018 | Year | 12 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2017 | Year | 11 | Month | 24 | Day |
Last modified on
| 2023 | Year | 07 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034366
